Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
UAB 1018/TBCRC 011; Bicalutamide for the Treatment of Androgen Receptor Positive (AR(+), Estrogen Receptor Negative, Progesterone Receptor Negative (ER(-)/PR(-), Metastatic Breast Cancer Patients: A Phase II Feasibility Study
Grant
Overview
Affiliation
Overview
Awarded By
Johns Hopkins University
Total Award Amount
28600.00
Direct Costs
26000.00
Sponsor Award Id
2001102334
Affiliation
Contributor
Lisle Nabell M.D.
Investigator